Big Pharma’s Role in Stem Cell Therapy

Name: Big Pharma’s Role in Stem Cell Therapy
Uploaded: 2025-02-24T13:00:51+00:00
Duration: 31 s
Channel: Dr. Charles Mok
Description: Dr. Charles Mok argues the FDA favors big pharma by approving ineffective drugs and treating stem cell therapies as expensive products rather than…

24 Feb 2025 · 1 min

Watch on YouTube

0:31

Dr. Charles Mok argues the FDA favors big pharma by approving ineffective drugs and treating stem cell therapies as expensive products rather than procedures. He points to Cellularity's high-priced FDA-approved stem cell product as evidence that commercial incentives shape regulatory decisions.

Chapters

The government has been trying to regulate stem cells, mostly because the FDA is, I would say, in the pocket of big Pharma. But they work for big Pharma. They're trying to approve drugs. They sensitively are trying to make drugs safe for consumers. But we can see several times where they approved drugs that really didn't work, that got the backing of the fda, as if they did work. And this does happen in stem cells. We consider this more of a surgical procedure and is currently a company, Cellularity, that's trying to make a stem cell product FDA approved. They can sell it at a gajillion dollars. And I think that's led the FDA to maybe start looking at ste.